Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PW Medtech Group Ltd. ( (HK:1358) ) has shared an update.
PW Medtech Group Ltd. reported a significant increase in revenue for the first half of 2025, amounting to approximately RMB414.4 million, a 22.4% rise compared to the same period in 2024. Despite the revenue growth, the company’s profit for the period decreased by 7.5% to approximately RMB86.6 million. The board declared an interim dividend of HK4.4 cents per share, slightly lower than the previous year’s HK4.5 cents, reflecting a cautious approach amid fluctuating profits.
The most recent analyst rating on (HK:1358) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on PW Medtech Group Ltd. stock, see the HK:1358 Stock Forecast page.
More about PW Medtech Group Ltd.
Average Trading Volume: 2,314,945
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.07B
For a thorough assessment of 1358 stock, go to TipRanks’ Stock Analysis page.